{"id":296392,"date":"2026-07-04T21:43:33","date_gmt":"2026-07-04T21:43:33","guid":{"rendered":"https:\/\/www.europesays.com\/se\/296392\/"},"modified":"2026-07-04T21:43:33","modified_gmt":"2026-07-04T21:43:33","slug":"paretos-vantar-sig-gora-stora-prognossankningar-efter-devysers-vinstvarning","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/296392\/","title":{"rendered":"Paretos v\u00e4ntar sig g\u00f6ra stora prognoss\u00e4nkningar efter Devysers vinstvarning"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Pareto v\u00e4ntar sig g\u00f6ra stora prognoss\u00e4nkningar efter diagnostikbolaget Devysers vinstvarning f\u00f6r det andra kvartalet.\n <\/p>\n<p>Int\u00e4kterna f\u00f6r andra kvartalet uppgick prelimin\u00e4rt till 60,2 miljoner kronor, omkring 20 procent under analyshusets prognos, till f\u00f6ljd av lageruppbyggnad hos den st\u00f6rsta distribut\u00f6ren, som Pareto bed\u00f6mer \u00e4r Thermo Fisher.\n <\/p>\n<p>Pareto r\u00e4knar nu med att s\u00e4nka f\u00f6rs\u00e4ljningsprognoserna f\u00f6r 2026-2028 med 12-19 procent och ebitprognoserna med \u00f6ver 50 procent. Riktkursen 140 kronor v\u00e4ntas ocks\u00e5 justeras ned.\n <\/p>\n<p>Den prelimin\u00e4rt reviderade prognosen inneb\u00e4r i princip ingen tillv\u00e4xt under 2026, medan tillv\u00e4xten f\u00f6r 2027-2028 prelimin\u00e4rt s\u00e4nks till 15 procent fr\u00e5n cirka 20 procent.\n <\/p>\n<p>&#8221;V\u00e5r tes har varit en ih\u00e5llande tillv\u00e4xt som lett till snabb marginalf\u00f6rb\u00e4ttring. Denna vinstvarning d\u00e4mpar den bilden&#8221;, skriver Pareto.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Leo Luthander<br \/>\n <br class=\"col-start-2\"\/><br \/>\n leo.luthander@finwire.se<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Pareto v\u00e4ntar sig g\u00f6ra stora prognoss\u00e4nkningar efter diagnostikbolaget Devysers vinstvarning f\u00f6r det andra kvartalet. Int\u00e4kterna f\u00f6r andra kvartalet&hellip;\n","protected":false},"author":2,"featured_media":296393,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,6580,70,71,34,31,33,32,30],"class_list":["post-296392","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-devyser-diagnostics","tag-economy","tag-ekonomi","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116863894102890544","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/296392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=296392"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/296392\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/296393"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=296392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=296392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=296392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}